http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-59589-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01600364c2f06b26af9f83f4935ecef0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 1986-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1994-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IE-59589-B1
titleOfInvention Pharmaceutical formulations with controlled release of the active substance
abstract The invention relates to a sustained-release formulation for oral administration, comprising a substance chosen from pindolol and an ester of 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydroxy-2,6-dimethyl- 3,5-pyridinedicarboxylic acid, a pharmaceutically acceptable hydrophilic swelling substance and optionally a pharmaceutically acceptable inert fat.
priorityDate 1985-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432359825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114690
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414867404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419542180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448718630
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10889
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154303425

Total number of triples: 40.